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ABSTRACT  23 
Pseudomonas aeruginosa colonizes the sputum of most adult cystic fibrosis patients, forming 24 
hard to eradicate biofilms, in which bacteria are protected in their self-produced EPS-matrix. EPS 25 
provides biofilms with viscoelastic properties, causing time-dependent relaxation after stress-26 
induced deformation, according to multiple characteristic time-constants. These time-constants 27 
reflect different biofilm (matrix) components. Since viscoelasticity of biofilms has been related 28 
with antimicrobial penetration, but not yet with bacterial killing, this study aims to relate killing 29 
of P. aeruginosa in its biofilm-mode of growth by three antimicrobials with biofilm 30 
viscoelasticity. P. aeruginosa biofilms were grown for 18 h in a constant depth film fermenter, 31 
either with mucin-containing artificial sputum medium (ASM
+
), artificial sputum medium 32 
without mucin (ASM
-
), or Luria-Bertani broth (LB). This yielded 100 µm thick biofilms, that 33 
differed in their amounts of matrix eDNA and polysaccharides. Low-load-compression-testing 34 
followed by three-element Maxwell analyses, showed that the fastest relaxation component, 35 
associated with unbound water, was most important in LB-grown biofilms. Slower components 36 
due to water with dissolved polysaccharides, insoluble polysaccharides and eDNA, were most 37 




-grown biofilms showed intermediate 38 
stress relaxation. P. aeruginosa in LB-grown biofilms were killed most by exposure to 39 
tobramycin, colistin or an antimicrobial peptide, while ASM
+
 provided the most protective matrix 40 
with less water and most insoluble polysaccharides and eDNA. Concluding, stress relaxation of 41 
P. aeruginosa biofilms grown in different media revealed differences in matrix composition that, 42 
within the constraints of the antimicrobials and growth media applied, correlated with the matrix 43 
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 48 
INTRODUCTION 49 
Gram-negative Pseudomonas aeruginosa biofilms play an important role in chronic wound 50 
infections, otitis media, biomaterial-associated infections and cystic fibrosis (CF) pneumonia (1). 51 
CF is characterized by the formation of thick mucus layers in the lungs, which makes it a suitable 52 
environment for P. aeruginosa to form biofilms (2). Approximately 80% of all adult CF patients 53 
are chronically infected by mucoid P. aeruginosa, which results in chronic illness and potentially 54 
death (3). Biofilm infections, including CF, are difficult to treat because the infecting bacteria 55 
surround themselves in a self-produced matrix of extracellular polymeric substances (EPS) (4). 56 
This can result in up to 1000 times larger recalcitrance to antimicrobials than planktonic bacteria 57 
possess (5). Multiple mechanisms have been described for this recalcitrance of bacteria in a 58 
biofilm-mode of growth, such as reduced metabolic activity, presence of persister cells and 59 
hampered penetration of antimicrobials into biofilms (3). The EPS matrix in P. aeruginosa 60 
biofilms mainly consists of water, proteins, lipids, eDNA and polysaccharides (6). The hallmark 61 
of CF infections caused by P. aeruginosa is the overproduction of polysaccharides, which 62 
negatively impacts survival of CF patients (7) as it facilitates strong bacterial binding and 63 
therewith hampering clearance from the lungs as well as providing protection against the host 64 
immune system and antimicrobials.  65 
EPS provides biofilms with viscoelastic properties. Elasticity relates to an immediate 66 
return of a material to its original shape after stress application, while viscoelasticity is the time-67 
dependent, partial resumption of the original shape of a material after being deformed. The time-68 













analysis (8–10) to identify different stress relaxation processes occurring in a biofilm. 70 
Empirically, stress relaxation in biofilms has been divided in a fast relaxation (stress relaxation 71 
time range 0 - 5 s) due to fast flow of water with its low viscosity, a slow component (> 100 s) 72 
related to re-positioning of bacterial cells and an intermediate component (5 - 100 s) caused by 73 
flow of more viscous EPS. Chlorohexidine penetration and bacterial killing in oral biofilms 74 
related with biofilm viscoelasticity, decreasing with increasing prevalence of the fastest, water-75 
due component and increasing with decreasing prevalence of the slowest component associated 76 
with bacterial re-arrangement (8). Accordingly, viscoelasticity of a biofilm has been called a 77 
virulence factor
 
(11). More detailed principal component analysis attributed stress relaxation time 78 
ranges to three principal components due to water and soluble polysaccharides (0.01 – 3 s), EPS 79 
components, like insoluble polysaccharides (3 – 70 s), comprising a principal component 80 
exclusively due to eDNA (10 – 25 s) (9). Collectively, these relatively fast components related 81 
inversely with slow stress relaxation possessing time range constants >70 s, while being due to 82 
bacterial cell re-arrangement (9).  83 
However, although the viscoelastic properties of biofilms have been related to the 84 
combined effects of antimicrobial penetration and killing that jointly define “recalcitrance”, no 85 
direct relation between the viscoelasticity of a biofilm and antimicrobial killing has been 86 
established. Therefore, the aim of study is to relate the viscoelasticity of P. aeruginosa biofilm 87 
with the killing of biofilm inhabitants by tobramycin, colistin or an antimicrobial peptide at 88 
different concentrations. To this end, P. aeruginosa biofilms were grown in a constant depth film 89 
fermenter (CDFF) in mucin containing artificial sputum medium (ASM
+
), bearing similarity to 90 
the lung environment (12), artificial sputum medium without mucin (AMS
-
) or Luria-Bertani 91 













determined from the stress relaxation of deformed biofilm and subsequent Maxwell analyses of 93 
the relaxation time-constants.  94 
 95 
RESULTS  96 
Growth rate and antimicrobial susceptibility of planktonic P. aeruginosa in different 97 
media. No differences were observed in the growth rate of planktonic, mucoid P. aeruginosa 98 




, or LB (Fig. 1a). 99 
The minimal bactericidal concentrations (MBC) against planktonic P. aeruginosa ATCC 39324 100 
grown in different media are shown in the Table inset to Fig. 1 (Fig. 1b). Tobramycin and colistin 101 
yielded the same MBC regardless of the growth medium used, but for the antimicrobial peptide 102 




 was 4 times higher than of 103 
bacteria grown in LB.  104 
Characteristics and matrix composition of differently grown P. aeruginosa biofilms. 105 





 and LB for 18 h, employing wells with a depth of 100 µm (13). Biofilms were 107 
imaged using optical coherence tomography (OCT) and using confocal laser scanning 108 
microscopy (CLSM) after staining (Figs. 2a and 2b, respectively). 2D cross-sectional OCT 109 
images (Fig. 2a) confirmed that on average, all biofilms grown were 100 µm thick (Fig. 3a), 110 
irrespective of the growth medium applied. Standard deviations over the thickness of biofilms 111 
grown in ASM
+
 medium with a surplus of mucin (22%; over three different CDFF runs, taking 112 
10 biofilms out of each run) were on average two-fold larger than of biofilms grown in absence 113 
of a surplus of mucin (11% in both ASM
-
 and LB medium). In CLSM images, biofilms grown 114 
with ASM
+
 showed a heterogeneous distribution of microcolonies surrounded by microchannels 115 













and less obvious microchannels. Biofilms grown with ASM
-
 displayed an intermediate structure 117 
compared to the biofilms in ASM+ and LB media. COMSTAT analysis demonstrated no 118 





 and LB also showed no significant differences (Fig. 3c). 120 




 biofilms and higher than in 121 
the LB biofilms. Polysaccharides concentrations (Fig. 3e) were similar in ASM
-
 and LB biofilm, 122 
while highest in the ASM
+
 biofilm. No differences were found in protein concentration (Fig. 3f) 123 
and water content (Fig. 3g). Significant differences in P. aeruginosa biofilm characteristics are 124 
summarized in Table 1. 125 
Viscoelastic properties of differently grown P. aeruginosa biofilms. Biofilms were 126 
compressed within 1 s to 80% of their initial thickness, equivalent to a strain () of 0.2. 127 
Normalized stress on the biofilms required to maintain the same deformation decreased with time 128 
(Fig. 4a), showing relatively slow stress relaxation for ASM
+
 grown biofilms, while LB grown 129 
biofilms relaxed fastest. All biofilms showed near full stress relaxation towards 100 s. Stress 130 
relaxation as a function of time was fitted to a three element Maxwell model. Inclusion of more 131 
Maxwell elements did not yield a better quality of the fit (Fig. 4b). LB grown biofilms showed a 132 





 grown biofilms, with ASM
+
 grown biofilms showing the lowest relative importance of 134 
the fastest relaxation time range (Fig. 4c). Relative importance of the other relaxation time 135 
constants ranging up to 25 s, was highest for ASM
+
 and lowest for LB grown biofilms (see also 136 
Table 1).  137 
Antimicrobial killing in differently grown P. aeruginosa biofilms. Biofilms were 138 
exposed for 24 h to PBS or PBS containing tobramycin, colistin or the antimicrobial peptide AA-139 













Fig. 1B). Tobramycin concentrations applied were 1000, 2500 and 5000 µg/ml, equivalent to 141 
62x, 156x and 313x MBC, respectively. Colistin was applied at concentrations of 1000 and 2500 142 
µg/ml, equivalent to 8x and 20x MBC, respectively. For tobramycin and colistin, MBC-fold 143 
concentrations were independent of growth medium (see also Fig. 1b), but for the antimicrobial 144 
peptide AA-230 the concentrations applied (5000 and 10,000 µg/ml) yielded different MBC-fold 145 




media (39x and 78x MBC, respectively) 146 
than for bacteria grown in LB medium (156x and 313x MBC, respectively). After antimicrobial 147 
exposure, biofilms were dispersed and the number of CFUs in the biofilms counted, taking PBS 148 




, regardless of the growth 149 
medium applied (Fig. 5). All antimicrobial exposures resulted in a significant decrease in 150 
CFU/cm
2





grown biofilms showed significantly higher numbers of CFUs, i.e. lower killing 152 





 grown biofilms. 154 
 155 
DISCUSSION  156 
This study demonstrates that P. aeruginosa ATCC 39324 biofilms grown to a thickness of 157 
100 µm in a CDFF possess different matrix compositions when grown in different growth media 158 
(Fig. 3) and allow different degrees of killing of its bacterial inhabitants by antimicrobials (Fig. 159 
5). Maxwell analyses showed that the fastest relaxation component, associated with unbound 160 
water, was most important in LB grown biofilms (Fig. 4c), but in absence of obvious 161 
microchannels (Fig. 2b). Slower stress relaxation components due to water with dissolved 162 
polysaccharides, insoluble polysaccharides and eDNA were most important in relaxation of 163 
ASM
+
 grown biofilms. ASM
-













aeruginosa in LB grown biofilms were killed most by exposure to tobramycin, colistin or an 165 
antimicrobial peptide, possibly due to the transport options provided by water. Biofilm growth in 166 
ASM
+
 provided the most protective matrix with less unbound water and most insoluble 167 
polysaccharides and eDNA, that maximally hampered penetration and killing. Interestingly, this 168 
statement coincides with the observation of microchannels in ASM
+
 grown biofilm (Fig. 2b). 169 
Since microchannels by definition have a transport function (14), this suggests that matrix 170 
composition may be more important than the possession of clear channel-like structures for the 171 
transport of antimicrobials in a biofilm. Concluding, stress relaxation analysis (Fig. 4) of P. 172 
aeruginosa biofilms grown in different media revealed differences in matrix composition (Fig. 3) 173 
that, within the constraints of the antimicrobials and growth media applied, correlated with the 174 
matrix protection offered against different antimicrobials (Fig. 5). Without the use of a CDFF, it 175 
would have been impossible to carry out this study because use of different growth media would 176 
have yielded biofilms with different thickness (15–18). 177 
Two artificial sputum media were used, mimicking the environment of the lung of CF 178 
patients and a nutrient-rich, laboratory medium (LB). In artificial sputum media, biofilms 179 
possessed more matrix eDNA and polysaccharides than biofilms grown in LB. The possession of 180 
more eDNA and polysaccharides yielded different stress relaxation behavior of the biofilms, with 181 
a higher importance of time relaxation ranges between 3 to 10 s and 10 to 25 s, respectively. This 182 
is fully in line with previous analyses of stress relaxation time ranges of biofilms from a wide 183 
variety of different strains and species with known matrix amounts of eDNA and polysaccharides 184 
(9). Both eDNA and polysaccharides act as a glue in biofilms and growth in artificial sputum 185 
medium accordingly gave more compact biofilms with condensed microcolonies in comparison 186 
with LB grown biofilms (Fig. 2b), in line with literature (15, 19). The arrangement of bacteria in 187 













relaxation, which explains their slower relaxation (Fig. 4a). Although growth media were selected 189 
that mimic the environment of the lungs, it is virtually impossible to select a substratum material 190 
to grow the biofilms upon that also mimics the in vivo situation. However, considering the use of 191 
CDFF-grown biofilms, compressed by the scraper-action and the limited calling distance of 192 
quorum-sensing molecules in a biofilm, it may be expected that over the 100 µm thickness of the 193 
Pseudomonas biofilms studied, influences of the substratum may have averaged out (20).   194 
LB grown biofilms demonstrated a stronger influence of water (relaxation times < 0.75 s) 195 
than biofilms grown in artificial sputum media (see also Table 1), although dry weight 196 
measurement of the percentage water in the biofilms were too insensitive to reflect differences 197 
with biofilms grown in other media (see Fig. 3a). Note that previously, relaxation time constants 198 
up to 3 s were taken together
 
(9), while we here separate this relaxation time constant range into 199 
two relaxation time ranges, attributing the time constant range between 0.75 and 3 s to more 200 
viscous water with dissolved polysaccharides. Through this distinction, the role of undissolved 201 
polysaccharides as a glue becomes reflected in stress relaxation analysis of biofilms. 202 
Tobramycin, colistin and AA-230 are all hydrophilic antimicrobials and have a similar 203 
positive charge at physiological pH (21–23). The molecular weight of tobramycin is 468 g/mol, 204 
of colistin is 1156 g/mol and of AA-230 2578 g/mol. This makes it interesting to compare 205 
bacterial killing by these antimicrobials at equivalent molar concentrations. At an equivalent 206 
molar concentration between 1.9 and 2.1 µM, corresponding with tobramycin, colistin and AA-207 
230 concentrations of 1000, 2500 and 5000 µg/ml respectively, colistin showed higher killing 208 
than tobramycin and AA-230, which is unexpected (24) because colistin with its higher molecular 209 
weight will diffuse more slowly into a biofilm at a similar molar concentrations. Moreover, 210 
expressing antimicrobial concentrations in MBC-fold equivalents, a molar concentration of 2.1 211 













MBC-fold concentrations of tobramycin or AA-230 at a similar molar concentration.  Likely, 213 
these differences in killing efficacy are due to their different modes of killing: tobramycin works 214 
on the inhibition of protein synthesis, and colistin on the destruction of the bacterial cell 215 
membrane (22, 25). The antimicrobial peptide AA-230 with the highest molecular weight, has a 216 
similar mode of action and accordingly showed less killing than colistin due to hampered 217 
penetration. Penetration of all three cationic antimicrobials will likely be hampered by the high 218 
concentrations of eDNA and polysaccharides in the artificial sputum grown biofilms due to 219 
electrostatic double-layer attraction with negatively charged bacterial cell surface components 220 
(23, 26–29). Moreover, eDNA in the biofilms induces production of spermidine and amino-221 
arabinose on the outer membrane, thereby reducing the permeability to aminoglycosides such as 222 
tobramycin (27) and leading to a decreased killing efficacy in biofilms grown in the artificial 223 
sputum media. In addition, the presence of mucin also can give rise to a higher tolerance for 224 
tobramycin (19). However, this effect is probably of minor importance, as differences in killing 225 
of P. aeruginosa biofilms grown in artificial sputum medium with or without mucin are small 226 
(see also Fig. 5). 227 
 In conclusion, 1) viscoelastic properties of P. aeruginosa biofilms grown in a CDFF and 228 
in different media differ due to possession of different amounts of water, (in)soluble 229 
polysaccharide and eDNA concentrations and 2) within the constraints of the antimicrobials and 230 
growth media applied, these properties relate with antimicrobial bacterial killing in the biofilm. 231 
More unbound water and less EPS, i.e. polysaccharides and eDNA, as in LB-grown biofilms 232 
facilitated higher killing than a less aqueous matrix with more EPS, as in ASM
+
-grown biofilms.  233 
 234 













Bacterial cultures and medium. P. aeruginosa ATCC 39324, a clinical CF isolate 236 
(mucoid phenotype) was cultured on a blood agar plate and a single colony was used to inoculate 237 
10 ml of tryptone soya broth (TSB, OXOID, Basingstoke, England) for aerobic incubation at 238 
37°C. After 24 h, this pre-culture was added to 200 ml of TSB and incubated aerobically at 37°C 239 
for 16 h under rotary-shaking at 150 revolutions per min (RPM), after which bacteria were 240 
harvested by centrifugation (5,000 X g, 5 min, 10°C). Bacterial pellets were washed two times 241 
with 10 ml sterile phosphate buffered saline (PBS, 10 mM potassium phosphate, 150 mM NaCl, 242 
pH 7.0) and bacteria were resuspended in 10 ml sterile PBS and bacterial concentrations 243 
determined using a Bürker-Türk counting chamber.  244 
 Planktonic growth rate. In order to investigate whether P. aeruginosa growth rates were 245 
similar in the different media, bacteria were suspended to 10
4
 CFU/ml in 40 ml of artificial 246 
sputum medium (12) (ASM
+
: per liter: 4 g DNA, 5 g mucin, 5 ml egg yolk emulsion, 4.75 g 247 
casamino acids, 0.25 g L-tryptophan, 5 g NaCl, 2.2 g KCl, pH 7.0), artificial sputum medium 248 
without mucin (ASM
-
), and LB, and incubated at 37°C under rotary-shaking at 150 RPM. At time 249 
0 and after 3, 6, and 24 h, 200 µl aliquots were taken and 10-fold serially diluted in sterile PBS. 250 
Two 10 µl droplets of each dilution were spotted on a tryptone soya agar plate and incubated 24 h 251 
at 37°C, after which the numbers of colony forming units were counted and expressed as 252 
CFU/ml.  253 
Minimal bactericidal concentration (MBC). Two-fold serial dilutions from 512 to 1 254 




 and LB, each with a 255 
total volume of 100 µl. For control, wells filled with growth medium in absence of antimicrobials 256 
were used. Bacteria were diluted to a concentration of 2 × 10
6 





or LB and 100 µl of bacterial suspension was added to each well to yield a total volume in the 258 













spotted on tryptone soya agar plates, after which the plates were incubated at 37°C for 24 h. The 260 
lowest antimicrobial concentration not showing visible bacterial colonies was taken as the MBC. 261 
 Biofilm growth. Biofilms were grown in a sterile constant depth film fermenter (CDFF) 262 
(13, 30) at 37°C on stainless steel disks. The sterile disks were placed in each of the 5 wells of a 263 
pan, placing 15 pans in the turntable of the CDFF. The thickness of the biofilms in the pans was 264 
controlled by setting the well depth such to leave 100 µm above the disks for the biofilm to grow. 265 
An amount of 200 ml bacterial suspension in TSB containing 5 × 10
7
 bacteria/ml was introduced 266 
in the CDFF during1 h, while the turntable was rotating at 3 RPM. Rotation was stopped for 30 267 




 or LB) was introduced 268 
and rotation continued. The biofilm was grown for 18 h and medium flow was continuous at a 269 
flow rate of 16 ml/h. After 18 h, disks with adhering biofilms were aseptically taken out of the 270 
pans for further experiments.  271 
Miscellaneous properties of differently grown biofilms. To determine the average 272 
thickness of biofilms, OCT (Ganymede-II, Thorlabs, Lubeck, Germany) was used. Biofilms were 273 
submerged in PBS, and a series of 2D, cross-sectional images of the biofilms were generated 274 
(1500 x 372 pixels). The average thickness of the biofilm was derived from the 2D cross-275 
sectional images using Otsu-thresholding (31).  276 
Biofilms were stained using SYTO9 (bacLight
tm
, Invitrogen, Breda, The Netherlands) 277 
live stain for 30 min in the dark to reveal biofilm structure. After staining, biofilms were 278 
immersed in PBS and images were taken with a confocal laser scanning microscope (CLSM, 279 
Leica TCS-SP2, Leica microsystems GmbH, Heidelberg, Germany) with a 40× water objective 280 
lens. Images were analyzed using Fiji (32), Imaris (Bitplane, Belfast, UK) and COMSTAT 2.1 281 













In order to investigate whether P. aeruginosa biofilms grown in the different media had 283 
similar metabolic activity, biofilms were exposed to 200 µl (3-(4,5-Dimethylthiazol-2-yl)-2,5-284 
Diphenyltetrazolium Bromide (MTT, 0.75 mg/ml) dissolved in sterile PBS at 37°C for 2.5 h. In 285 
metabolic active bacteria, MTT is intracellularly reduced to formazan. Following the incubation, 286 
biofilms were washed using PBS, and 1 ml of isopropanol was added to dissolve the formazan 287 
crystals inside the bacterial cells, and the optical density of the solution was measured at 575 nm 288 
using a FLUOstar optima plate reader (BMG Labtech GmbH, Offenburg, Germany). 289 
Matrix composition. For eDNA concentration, 1 ml eDNA extraction buffer (10 mM 290 
EDTA, 0.9% NaCl) was added to individual biofilms taken over three CDFF runs and 5 biofilms 291 
per CDFF run, vortexed and resuspended until the biofilm was fully detached from the 292 
substratum disk. Dispersed biofilms were centrifuged (5000 X g, 5 min, 10°C) to remove intact 293 
bacterial cells along with intracellular DNA. eDNA isolation was done using the phenol 294 
chloroform method (9). RNase was added to the eDNA after isolation and incubated for 30 min at 295 
37°C, after which the concentration of eDNA was measured using the ratio of absorbance at 260 296 
nm and 280 nm with the nanodrop-method.  297 
 For both polysaccharides and protein determination, five biofilms from different pans 298 
within one CDFF run were pooled and resuspended in 500 µl sterile PBS and vortexed for 1 min 299 
to detach the biofilms from the substratum disks. This was done in triplicate, with separated 300 
CDFF runs. Resuspended biofilms were centrifuged (5,000 X g, 5 min, 10 °C) to remove 301 
bacterial cells, after which 400 µl of supernatant was collected. Supernatant was immediately 302 
placed on ice and used for both polysaccharides and protein determination. 303 
Protein concentration was measured with the Pierce BCA Protein Assay Kit (Thermo 304 
Scientific, Waltham, USA), using the microplate procedure. Briefly, 25 µl sample from the 305 













curve) was added to 200 µl working reagent, and mixed for 30 s. Plates were incubated for 30 307 
min at 37°C, after which plates were cooled down to room temperature, and absorbance at 560 308 
nm was measured using a FLUOstar optima plate reader. 309 
Polysaccharide determination was performed using the colorimetric assay for glucose-310 
based carbohydrates (35). For the glucose based carbohydrates method, 40 µl of supernatant or a 311 
glucose solution (4096 to 1 µg/ml used for the calibration curve) was added to a 96-well plate and 312 
placed in the refrigerator for 15 min. 100 µl of anthrone solution (2 mg/ml in H2SO4) was added 313 
to the wells, mixed, and incubated for 3 min at 92°C, after which plates were placed in a water 314 
bath at room temperature for 15 min. Absorbance at 590 nm was measured and compared against 315 
glucose calibration curve with a FLUOstar optima plate reader  316 
To determine the water percentage in the biofilms, the wet weight of the disk and biofilm 317 
was measured using an analytical balance (Mettler Toledo model XP105DR, Columbus, USA). 318 
Prior to weighing, the bottom and the sides of the disks were carefully dried with a tissue, after 319 
which their weights were measured. Then, the disks with biofilms were dried at 60°C in a 320 
vacuum oven for at least 24 h, and weighted again. Afterwards the dried biofilm was removed 321 
from the disk and the disk alone was weighted. With this data, the dry weight and water 322 
percentage of the biofilms was calculated. 323 
Viscoelastic properties of P. aeruginosa biofilms. Viscoelastic properties of the biofilms 324 
were determined by using the low-load-compression-tester (LLCT) (36). To this end, a small part 325 
of a substratum disks was cleaned to enable determination of the substratum surface using LLCT 326 
plunger (2.5 mm diameter). After determining the position of the substratum surface, the position 327 
of the biofilm surface was determined by compressing the biofilm with a small “touch level” of 328 













and held constant for 100 s, while measuring stress relaxation. Stress relaxation ((t)) was 330 
measured as a function of time t during 100 s and normalized with respect to strain according to 331 




           (1) 333 
 334 
Normalized stress relaxation as a function of time E(t) was fitted to a three element, generalized 335 
Maxwell model, using the solver tool in Microsoft Excel 2010. according to 336 
















      (2) 338 
 339 
where i = i/Ei is the relaxation time constant, Ei is the spring constant and i is the viscosity 340 
term for each Maxwell element i. In order to indicate the relative importance of each relaxation 341 
process RIi, defined as 342 
 343 
𝑅𝐼𝑖=𝐸𝑖 /((𝐸1+𝐸2+𝐸3)× 100%        (3) 344 
 345 
was calculated for each element and elements were placed in six relaxation time ranges. 346 
Antimicrobial exposure of P. aeruginosa biofilms and bacterial killing. Biofilms were 347 
exposed to different concentrations of tobramycin (5000, 2500, 1000 µg/ml) or colistin sodium 348 













GmbH (Steinheim, Germany), and the antimicrobial peptide AA-230 (10000, 5000 µg/ml), 350 
supplied by Adenium Biotech (Copenhagen, Denmark) and synthesized by PolyPeptide (Malmö, 351 
Sweden). Tobramycin and colistin are both used against P. aeruginosa infections in CF patients. 352 
All antimicrobials were dissolved in sterile PBS. A 20 µl drop of sterile PBS or antimicrobial 353 
solution was pipetted on the biofilm. The plate was sealed with parafilm to prevent evaporation 354 
and incubated 24 h at 37°C. Concentrations were chosen well above the MBC of each 355 
antimicrobial against planktonically-grown P. aeruginosa. After antimicrobial exposure, biofilms 356 
were washed with sterile PBS, 1 ml sterile PBS added and vortexed for 1 min, to disrupt the 357 
biofilm and detach the bacteria from the substratum disk. Finally, dispersions were sonicated in a 358 
sonication bath for 5 min to disrupt bacterial aggregates, which did not cause bacterial death (data 359 
not shown). Samples were 10-fold serially diluted and two 10 µl drops of each dilution were 360 
spotted on tryptone soya agar and incubated at 37°C. After 24 h, colonies were counted and the 361 
number of CFU per cm
2 
substratum surface calculated. 362 
Statistical analysis. Statistical analysis was performed with Graphpad Prism version 5.00 363 
for Windows (GraphPad Software, La Jolla California USA). Differences in biofilm thickness, 364 
viscoelastic properties, biofilm recalcitrance to antimicrobials and EPS components were 365 
evaluated after normality testing. Analysis of variance (ANOVA) was performed to test 366 
significance between groups, either with a Dunn’s Post-hoc test or a Tukey post-hoc test, 367 
depending on normal or non-normal distribution. Data was accepted significant if p < 0.05. All 368 
data reported represent means with standard deviation, unless stated otherwise. 369 
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TABLE 1 Summary of the statistically significant differences in P. aeruginosa ATCC 39324 492 




 or LB media and their killing by antimicrobials 493 
(taking tobramycin, colistin and the antimicrobial peptide AA-230 together). = means no 494 
significant difference, > means significant difference at p < 0.05. 495 
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FIG 1 Planktonic growth curve and minimal bactericidal concentration (MBC) of P. aeruginosa 498 




 and LB medium. 499 
(a) The number of CFU/ml in planktonic cultures as a function of time in different growth media. 500 
Growth curves were done in duplicate, error bars denoting the difference between the two 501 
experiments. 502 
(b) MBC of planktonic P. aeruginosa upon 24 h exposure to the different antimicrobials in PBS. 503 
MBC values were determined in three-fold with separately grown bacterial cultures, yielding no 504 
differences in MBC values. 505 







































 and 508 
LB. 509 
(a) 2D, cross-sectional OCT images, with scale bars representing 200 µm. 510 
(b) CLSM 2D over-layer (left) and 3D (right) images of SYTO9 stained biofilms yielding green-511 
fluorescent bacteria. Scale bars represent 100 µm. 512 



















 and LB. 516 
(a) Thickness of the biofilms measured by OCT. 517 
(b) Biovolume of the biofilms obtained from COMSTAT analysis of CLSM images. 518 
(c) Metabolic activity of the biofilms measured with MTT. 519 
(d) eDNA presence in the biofilms, isolated with phenol chloroform and measured with the 520 
nanodrop-method. 521 
(e) Polysaccharide presence in the biofilms measured using anthrone sulfuric acid in a 522 
colorimetric assay. 523 
(f) Proteins presence in the biofilm, measured with Pierce BCA Protein Assay Kit. 524 
(g) Water content, obtained from a comparison of the weight of hydrated and dried biofilms and 525 













Error bars denote standard deviations over n (numbers given in the columns) different biofilms, 527 
taken from different pans in three separate CDFF runs, except for panels b and c which were 528 
taken from different pans in two separate CDFF runs. Markers indicate significant differences (p 529 
< 0.05, ANOVA with Tukey post-hoc analysis) between groups. 530 



















or LB medium. 534 
(a) Examples of the normalized stress in compressed biofilms (strain 0.2) as a function of 535 
relaxation time. Stress at t = 0 amounted 2.2 kPa for all biofilms, regardless of growth medium. 536 
(b) Quality of fitting the stress relaxation data to a generalized Maxwell model as a function of 537 
the number of elements included in the model. Quality of the fit is indicated by chi-squared 538 













(c) Distribution of the relative importance of individual Maxwell elements (three elements model) 540 
in differently grown P. aeruginosa biofilms over different relaxation time constant ranges. Each 541 
data point represents a single measurement out of 30 biofilms, taking 10 biofilms from different 542 
pans in three separate CDFF runs. Median values are indicated by horizontal lines. Markers 543 































) in P. aeruginosa ATCC 39324 559 




 or LB after exposure for 24 h to different concentrations of 560 
tobramycin, colistin or the antimicrobial peptide AA-230 in PBS, and including PBS as a control. 561 
Error bars denote standard deviations over at least 9 different biofilms, taken from different pans 562 
in three separate CDFF runs. Markers indicate significant differences (p < 0.05, ANOVA with 563 
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